Chacruna Institute for Psychedelic Plant Medicines is a registered California 501(c)(3) non-profit organization (EIN 84-3076078). We are a community-oriented organization run by a small staff of experts and enthusiastic volunteers who work to bring education and cultural understanding about psychedelic plant medicines to a wider audience. We promote a bridge between the ceremonial use of sacred plants and psychedelic science and envisage a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal, and health care systems.
Help us to achieve our mission! From our beginnings in 2017, we have stood apart from other psychedelic education and advocacy organizations by pioneering initiatives that support and provide a platform for diverse voices, including women, queer people, people of color, Indigenous people, and the Global South. In efforts to address the lack of diverse representation in the expanding psychedelic landscape, we centered our mission around the empowerment of marginalized voices to foster cultural and political reflections on topics like race, gender, and sexuality in psychedelic science. We believe now more than ever, given the current social and political climate, our work is critical to the future of psychedelic healing for humanity.
Please become a member so that you are able to help Chacruna, yourself, and the world. Support of any amount helps this cause and allows us to provide psychedelic education to anyone who wants to access it.
Founder and Executive Director
Bia Labate – Co-Founder and Executive Director
Dr. Beatriz Caiuby Labate (Bia Labate) is a queer Brazilian anthropologist based in San Francisco....
Wednesday, April 26th, 2023 from 12:00-1:30pm PST
Register for this event here.
This event is a partnership between Chacruna and Sociedade Brasileira de Genética Regional Leste.
This community...
In France, Santo Daime and other ayahuasca groups and practitioners are accused of illicit drug trafficking and brainwashing. This demonization of ayahuasca use leads to individuals being imprisoned for their religious beliefs and is a violation of their human rights.
In a survey published in 2021, Brazil ranked third place in recent high-impact biomedical studies with psychedelics, mainly because of ayahuasca research initiated in the 1990s. However, clinical experimenters and humanities scholars still go their separate ways, without much cross-pollination between the two fields. They are in a unique position, though, to join forces and go beyond the narrow medicalization paradigm underpinning the psychedelic renaissance.
A Canadian company, Filament Health, plans to develop ayahuasca pills. These pills promise to provide a standardized ayahuasca experience, but what does the commodification of ayahuasca mean for ethical consumption. Indigenous peoples with cultural and spiritual connections to ayahuasca need to be given the opportunity to provide full consent.
Monday, February 27th, 2023 from 12:00-1:30pm PST
Register for this event here.
The use of ayahuasca, an indigenous brew from the Amazonian basin with psychedelic properties, has...
January 24th – May 9th 2023, 10am-12pm PST/1pm-3pm EST
Price $1,100 USD
Price $560 for CE credits
In the midst of the current “renaissance” in psychedelic research,...
Chacruna celebrates Colorado's Natural Medicine Health Act (NMHA), a historic step in the decriminalization of psychedelic medicines. NMHA decriminalizes personal use, possession, cultivation, and adult sharing of five psychedelics.
February 6th – April 10th 2023, 10am-12pm PST/1pm-3pm EST
Price $450 USD
Price $280 for CE credits
This course is a partnership between Chacruna and University of...
In November 2022, Colorado will vote on the Natural Medicine Health Act, also known as Proposition 122. If passed, this act will legalize possession of psilocybin, ibogaine, DMT, and mescaline. In this article, Martha Hartney provides five key points of commentary on this proposed law.